Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Prana begins phase I trial for PBT-2

March 18, 2005

Repligen enters into development agreement for uridine for bipolar disorder

March 18, 2005

Phase I study of Acrux transdermal spray to prevent nausea in cancer patients

March 18, 2005

CGRP receptor antagonists reported by Merck

March 17, 2005

Ionix Pharmaceuticals described sodium channel blockers

March 17, 2005

European approval for Zonegran

March 17, 2005

Preclinical neuroprotective and cognitive-enhancing effects of EHT-0202

March 17, 2005

CEP-1347 inhibits the c-Jun N-terminal kinase cascade to evoke apoptosis

March 17, 2005

Clarithromycin reported to increase the antiparkinsonian effects of cabergoline

March 17, 2005

Viprinex set for phase III in the summer

March 17, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...